Lucy Therapeutics Appoints Kim Drapkin as Board Chair
15 Oct 2024 //
BUSINESSWIRE
LucyTx announces additional $12.5m research funding for neurological diseases
11 Jun 2024 //
PHARMA TIMES
Lucy Therapeutics: Funding For Alzheimer`s, Parkinson`s Treatments
28 May 2024 //
BUSINESSWIRE
Lucy Therapeutics Appoints Christopher J. Winrow as Chief Scientific Officer
29 Mar 2023 //
BUSINESSWIRE
Lucy Therapeutics Appoints Julia Gaebler as CBO
15 Nov 2022 //
BUSINESSWIRE
Lucy Therapeutics Appoints Julia Gaebler, Ph.D., as Chief Business Officer
15 Nov 2022 //
BUSINESSWIRE

Market Place
Sourcing Support